Interleukin-18, transforming growth factor-β, and vascular endothelial growth factor gene polymorphisms and susceptibility to primary glomerulonephritis

Tissue Antigens

Volumn 76, Issue 4, 2010, Pages 289-296

  Choi, H J ^a,b   Cho, J H ^b,b   Kim, J C ^a   Seo, H J ^b   Hyun, S H ^b   Kim, G H ^b   Choi, J Y ^b   Ryu, H M ^b   Park, S H ^b   Kim, Y L ^b   Han, S ^c   Kim, C D ^b  

^a Cha University   (South Korea)

^b Kyungpook National University Hospital   (South Korea)

^c Daegu Fatima Hospital   (South Korea)

Author keywords

glomerulonephritis; interleukin 18; polymorphism; transforming growth factor ; vascular endothelial growth factor

Indexed keywords

ALANINE; CYSTEINE; DNA; GLYCINE; INTERLEUKIN 18; THREONINE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DNA EXTRACTION; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENE FREQUENCY; GENETIC RECOMBINATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GLOMERULONEPHRITIS; HAPLOTYPE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KOREA; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLOMERULONEPHRITIS; HAPLOTYPES; HUMANS; INTERLEUKIN-18; MALE; POLYMORPHISM, GENETIC; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 77956312722     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2010.01515.x     Document Type: Article

References (23)

1. Mathieson PW. Glomerulonephritis. Semin Immunopathol 2007 : 29 : 315 316.
2. Chadban SJ, Atkins RC. Glomerulonephritis. Lancet 2005 : 365 : 1797 1806.
3. Kashtan C. Autotopes and allotopes. J Am Soc Nephrol 2005 : 16 : 3455 3457.
4. Schena FP, Gesualdo L, Grandaliano G, Montinaro V. Progression of renal damage in human glomerulonephritides: is there sleight of hand in winning the game? Kidney Int 1997 : 52 : 1439 1457.
5. Tipping PG, Kitching AR. Glomerulonephritis, Th1 and Th2: what's new? Clin Exp Immunol 2005 : 142 : 207 215.
6. Matsumoto K, Kanmatsuse K. Augmented interleukin-18 production by peripheral blood monocytes in patients with minimal-change nephrotic syndrome. Am J Nephrol 2001 : 21 : 20 7.
7. Matsumoto K, Kanmatsuse K. Elevated interleukin-18 levels in the urine of nephrotic patients. Nephron 2001 : 88 : 334 339.
8. Matsumoto K, Kanmatsuse K. Interleukin-18 and interleukin-12 synergize to stimulate the production of vascular permeability factor by T lymphocytes in normal subjects and in patients with minimal-change nephrotic syndrome. Nephron 2000 : 85 : 127 133.
9. Kilis-Pstrusinska K, Medynska A, Zwolinska D, Wawro A. Interleukin-18 in urine and serum of children with idiopathic nephrotic syndrome. Kidney Blood Press Res 2008 : 31 : 122 126.
10. Sato F, Narita I, Goto S et al. Transforming growth factor-beta1 gene polymorphism modifies the histological and clinical manifestations in Japanese patients with IgA nephropathy. Tissue Antigens 2004 : 64 : 35 42.
11. Okuda S, Languino LR, Ruoslahti E, Border WA. Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 1990 : 86 : 453 462.
12. Song CY, Kim BC, Hong HK, Lee HS. TGF-beta type II receptor deficiency prevents renal injury via decrease in ERK activity in crescentic glomerulonephritis. Kidney Int 2007 : 71 : 882 888.
13. Isaka Y, Nakamura H, Mizui M et al. DNAzyme for TGF-beta suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 2004 : 66 : 586 590.
14. Lim CS, Kim YS, Chae DW et al. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with susceptibility to and progression of IgA nephropathy. Clin Nephrol 2005 : 63 : 61 7.
15. Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 2004 : 65 : 2003 2017.
16. Masuda Y, Shimizu A, Mori T et al. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol 2001 : 159 : 599 608.
17. Lewontin RC. On measures of gametic disequilibrium. Genetics 1988 : 120 : 849 852.
18. Chen DY, Hsieh CW, Chen KS et al. Association of interleukin-18 promoter polymorphisms with WHO pathological classes and serum IL-18 levels in Chinese patients with lupus nephritis. Lupus 2009 : 18 : 29 37.
19. Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001 : 112 : 146 152.
20. Chow KM, Szeto CC, Lai FM, Poon P, Wong TY, Li PK. Genetic polymorphism of vascular endothelial growth factor: impact on progression of IgA nephropathy. Ren Fail 2006 : 28 : 15 20.
21. Paydas S, Balal M, Tanriverdi K, Sertdemir Y, Baslamisli F. The relationship between the VEGF levels and VEGF mRNA expression and clinical course in different glomerulonephritis. Ren Fail 2007 : 29 : 779 784.
22. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000 : 12 : 1232 1235.
23. van der Meer P, De Boer RA, White HL et al. The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy. J Card Fail 2005 : 11 : 279 284.